Baylor College Of Medicine
Clinical trials sponsored by Baylor College Of Medicine, explained in plain language.
-
Double immune attack: new cell combo targets tough childhood cancers
Disease control Not yet recruitingThis early-phase study tests a new combination of two different immune cells—NK cells and CAR-T cells—for children and young adults with neuroblastoma or osteosarcoma that has returned or not responded to standard treatments. The NK cells are designed to help the CAR-T cells work…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 02, 2026 06:00 UTC
-
Virtual program aims to help Hispanic/Latinx veterans better manage diabetes
Disease control Not yet recruitingThis study tests a 10-week virtual program called Acceptance Based Coping (ABaCo) for Hispanic/Latinx military patients with type 2 diabetes. The program, delivered by a bilingual health coach, teaches skills to cope with diabetes-related stress and improve self-care. Researchers…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Eye drop showdown: which cyclosporine works best for dry eyes?
Disease control Not yet recruitingThis study compares two approved cyclosporine eye drops—Vevye (0.1%) and a generic (0.05%)—in 60 adults with dry eye disease. Over 8 weeks, researchers will measure changes in goblet cells, which produce mucus to keep eyes moist. Participants use drops daily and visit the clinic …
Phase: PHASE4 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Engineered immune cells take on deadly childhood brain cancer
Disease control Not yet recruitingThis early-stage trial tests a new treatment for children with a rare, aggressive brain tumor called ATRT that has come back or not responded to standard therapy. The treatment uses the patient's own immune cells, modified in a lab to better recognize and attack the tumor, plus a…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Disposable scope could make gut surgery safer
Disease control Not yet recruitingThis pilot trial will test a disposable endoscope in 40 adults undergoing POEM procedures for achalasia or gastroparesis. The goal is to see if the single-use scope works as well as standard reusable scopes, potentially reducing infection risk. All participants receive standard c…
Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Engineered immune cells take on hard-to-treat breast cancer in new trial
Disease control Not yet recruitingThis early-phase trial tests a new type of cell therapy for people with metastatic HER2-positive breast cancer that has worsened after standard treatment. Researchers take a patient's own immune cells (T cells), add new genes to help them recognize and attack cancer cells, and re…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Engineered immune cells take aim at CD70-Positive cancers in new trial
Disease control Not yet recruitingThis early-phase trial tests a new type of immunotherapy called CD70 CAR T cells in people with lymphoma, myeloma, and certain solid tumors (like kidney cancer and sarcomas) that have come back or not responded to standard treatments. The immune cells are modified in the lab to r…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could vitamin c help protect the gut in transplant patients?
Disease control Not yet recruitingThis early-phase trial tests whether adding vitamin C to standard steroid treatment helps people with gastrointestinal graft-versus-host disease (GVHD), a serious complication after a donor stem cell transplant. About 35 participants aged 5 and older will receive vitamin C plus s…
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Engineered t cells take aim at stubborn leukemias in early trial
Disease control Not yet recruitingThis early-phase study tests a new type of immune therapy for people with certain blood cancers (leukemias) that have returned or not responded to standard treatments. The therapy uses the patient's own T cells, which are modified in the lab to recognize and attack cancer cells c…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can your own blood help regrow hair? new trial tests PRP for scarring hair loss
Disease control Not yet recruitingThis study tests whether platelet-rich plasma (PRP) injections can help treat central centrifugal cicatricial alopecia (CCCA), a scarring hair loss that mostly affects women of African descent. PRP is made from a patient's own blood and is thought to reduce inflammation and promo…
Phase: PHASE4 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
App-Based mind therapy tested for Kids' tummy troubles
Symptom relief Not yet recruitingThis study tests whether a mobile app that plays guided imagery sessions can help reduce chronic abdominal pain in children aged 7 to 12. Participants listen to 10-15 minute audio sessions five days a week for eight weeks, alongside their usual care. The goal is to see if this ap…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Brain scans and Decision-Making tasks aim to uncover OCD's hidden markers
Knowledge-focused Not yet recruitingThis study looks for brain-based markers (biomarkers) of obsessive-compulsive disorder (OCD) in people with severe, hard-to-treat symptoms. Participants complete decision-making tasks and are exposed to personal OCD triggers while their brain activity is recorded with EEG and the…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
Teens' tonsil surgery pain: which painkiller works best?
Knowledge-focused Not yet recruitingThis study observes pain levels in teenagers aged 13-18 after outpatient tonsil and adenoid removal. Participants receive either acetaminophen with ibuprofen or acetaminophen with oral ketorolac, based on their surgeon's usual practice. They report pain and recovery via text surv…
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Brain zap study aims to decode OCD's Approach-Avoidance conflict
Knowledge-focused Not yet recruitingThis study will implant deep brain stimulation devices in 10 adults with severe, treatment-resistant OCD to record brain activity during approach and avoidance tasks. Researchers will compare clinic-based and at-home recordings to find neural markers of OCD symptoms. The goal is …
Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a skin scan tell if your toddler eats enough veggies?
Knowledge-focused Not yet recruitingThis study will test whether a simple skin scan can accurately measure how many fruits and vegetables toddlers eat. Researchers will give 150 healthy 2-year-olds either applesauce or a fruit-vegetable puree for 4 weeks, then compare skin carotenoid levels with blood tests and foo…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC
-
Scientists to wire up brains and homes to decode OCD and bipolar behavior
Knowledge-focused Not yet recruitingThis study will follow 12 people with severe OCD or bipolar disorder who are already scheduled to receive deep brain stimulation (DBS). Researchers will use the DBS device to record brain activity while participants wear smart rings, watches, and phones to track sleep, activity, …
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC